The global stevia market is projected to expand from USD 1.03 billion in 2026 to USD 1.71 billion by 2031, representing a compound annual growth rate of 10.62%, according to market research firm Mordor Intelligence. This expansion reflects sustained demand for plant-based sweetening alternatives as consumers and manufacturers increasingly prioritize health considerations and seek to reduce sugar consumption across multiple product categories.
The growth trajectory is underpinned by several converging factors, including strengthened regulatory frameworks that validate stevia's safety profile and efficacy. Food and beverage manufacturers, along with pharmaceutical and nutraceutical companies, are integrating stevia into their product portfolios at accelerating rates, driven by both consumer preference shifts and evolving nutritional standards.
Technological improvements in bioconversion and precision fermentation processes are significantly enhancing stevia's commercial viability. These advances have improved taste quality while reducing production costs, removing barriers to wider market adoption and enabling stevia to compete more effectively with conventional sweetening solutions.